ClinicalTrials.gov
ClinicalTrials.gov Menu

Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00273624
Recruitment Status : Terminated
First Posted : January 9, 2006
Last Update Posted : May 13, 2016
Sponsor:
Information provided by (Responsible Party):
Claus Normann, University Hospital Freiburg

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2009
  Actual Study Completion Date : December 2009